The board of directors of Kaisa Health Group Holdings Limited announced that with effect from 5 March 2018, Mr. Guo Peineng resigned as an independent non-executive Director due to his decision to devote more time to other business engagements. Mr. Guo confirmed that he has no disagreement with the Board and there is no matter related to his resignation which needs to be brought to the attention of the shareholders of the company and The Stock Exchange of Hong Kong Limited. Following the resignation of Mr. Guo, Mr. Fok Hei Yu and Dr. Lyu Aiping have been appointed as independent non-executive Directors. Mr. Fok is a senior managing director of FTI Consulting Inc. Mr. Fok is currently an independent non-executive director of Shirble Department Store Holdings (China) Limited. Dr. Lyu is a member of the Chinese Medicine Development Committee in Hong Kong and a member of Biology and Medicine Panel of The Research Grants Council in Hong Kong. He also currently serves as a member of the Chinese Pharmacopoeia Commission of the People's Republic of China. Dr. Lyu had been focused on the translational research in Chinese medicine, including pharmacological and clinical evaluation on rheumatoid arthritis with traditional Chinese medicine pattern diagnosis and interventions, and development of new drugs based on Chinese medicines. Also Dr. Lyu is actively involving in the research on the standardization of Chinese medicine and strategic plan research for Chinese medicine development in China. Since 2009, Dr. Lyu has been appointed as the head of the Chinese delegation in the Technical Committee of the International Organization for Standardization on traditional chinese medicine (ISO/TC249). Over the years, Dr. Lyu obtained more than 60 patents from his research activities and published more than 30 books and over 500 articles. Following the resignation of Mr. Guo and appointments of Mr. Fok and Dr. Lyu, the Board further announces that with effect from 5 March 2018: Mr. Guo has ceased to be the chairman of the Remuneration Committee, and a member of each of the audit committee and the nomination committee of the company; and Mr. Fok has been appointed as the chairman of the Remuneration Committee and a member of each of the Audit Committee and the Nomination Committee.